23/11/2023 - 16:11

Chimeric drug declares war on deadly pancreatic cancer

23/11/2023 - 16:11


Save articles for future reference.

Chimeric Therapeutics’ mission to beat cancer with its “natural killer” therapy has hit a new high point, with test-tube studies showing a 300 per cent increase in its ability to kill the pancreatic form of the insidious disease. The company’s latest revelations also show its off-the-shelf “CLTX CAR NK” cell therapy recording a 260 per cent jump in killing ovarian cancer.

Subscribe today for award-winning, unbiased and trusted journalism

Subscription Options